Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hertelendy F and Zakár T Prostaglandins and the myometrium and cervix. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:14683694
Herron D et al. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides. 1995 Prostaglandins Leukot. Essent. Fatty Acids pmid:7630919
Gáti I et al. Effects of the PAF-analog and -antagonist CV-6209 on cultured human glioma cell lines. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:1886907
Mózes T et al. Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8446657
Shindo K et al. Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet activating factor from human alveolar macrophages. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9431823
Akisu M et al. Selective head cooling with hypothermia suppresses the generation of platelet-activating factor in cerebrospinal fluid of newborn infants with perinatal asphyxia. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12878450
Landgraf RG et al. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. 2007 Oct-Nov Prostaglandins Leukot. Essent. Fatty Acids pmid:17923399
Sugatani J et al. The role of platelet activating factor (PAF) in the pathogenesis of gastric ulcers. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:1808623
Cui S et al. L-NAME augments PAF-induced venoconstriction in isolated perfused livers of rat and guinea pig, but not mouse. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17395449
Becker K et al. Influence of some prostaglandins and prostaglandin analogues on PAF-induced shock in mice. 1990 Prostaglandins Leukot. Essent. Fatty Acids pmid:1696744
Hardy P et al. New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15850712
Mentz P et al. Interactions of prostanoids with the platelet activating factors. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1279731
Richter M et al. Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17448648
Louis NA et al. Lipid mediator networks and leukocyte transmigration. 2005 Sep-Oct Prostaglandins Leukot. Essent. Fatty Acids pmid:15979294
Akisu M et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic-ischemic brain in young mice. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468264
de Lima WT et al. Studies on the mechanism of PAF-induced vasopermeability in rat lungs. 1995 Prostaglandins Leukot. Essent. Fatty Acids pmid:7784472
Hughes H et al. PAF formation by H2O2-stimulated perfused canine carotid arteries. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:7846103
Albertini M and Clement MG In pigs, inhaled nitric oxide (NO) counterbalances PAF-induced pulmonary hypertension. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:7846107
Galli C et al. Modulation of lipid derived mediators by polyunsaturated fatty acids. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8424123
Tsunoda H et al. Involvement of leukotriene C4 in PAF-induced death in mice. 1990 Prostaglandins Leukot. Essent. Fatty Acids pmid:2353029
Ichimaru T and Tai HH Alteration of platelet activating factor (PAF) metabolism in rat pulmonary alveolar macrophages and plasma by cigarette smoking. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1461922
Becker K et al. PAF effects on eicosanoid release in neonatal rat cardiomyocytes. 1995 Prostaglandins Leukot. Essent. Fatty Acids pmid:7480082
Evans RD et al. Platelet-activating factor and its metabolic effects. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:1946557
Salamonsen LA Effect of platelet activating factor on prostaglandin release from ovine endometrial cells in culture. 1991 Prostaglandins Leukot. Essent. Fatty Acids pmid:1946564
Travis SP and Jewell DP The role of platelet-activating factor in the pathogenesis of gastrointestinal disease. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:8208748
Evangelou AM Platelet-activating factor (PAF): implications for coronary heart and vascular diseases. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:8146205
Shindo K and Fukumura M Azelastine hydrochloride inhibits platelet activating factor-like activity in human eosinophils. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8951989
Peplow PV and Mikhailidis DP Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolism. 1990 Prostaglandins Leukot. Essent. Fatty Acids pmid:2274568
Jeremy JY et al. Eicosanoids and septicaemia. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:7938078
Berdeli A et al. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15301793
Shindo K et al. Effect of azelastine hydrochloride on release and production of platelet activating factor in human neutrophils. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9175174
Clement MG et al. PAF and the role of the vagus nerve in the breathing pattern of the pig. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1561234
Saito M et al. Role of leukotrienes and platelet activating factor in allergic bronchoconstriction and their interactions in guinea pig airway in vivo. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8415807
Arribas I et al. Direct interactions between platelets and cultured rat mesangial cells. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8415809
Plante GE et al. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3231663
Becker K et al. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8385779
Wise H Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9482170
Peplow PV Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10509861
Shindo K and Fukumura M Oxatomide inhibits synthesis and release of platelet-activating factor in human neutrophils. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9578146
Martínez L et al. Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. 1999 Prostaglandins Other Lipid Mediat. pmid:10367296
Miguel BG et al. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. 2001 Prostaglandins Other Lipid Mediat. pmid:11444588
Travers JB et al. Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases. 1998 Prostaglandins Other Lipid Mediat. pmid:9990675
Balestrieri ML et al. Types of purinoceptors and phospholipase A2 involved in the activation of the platelet-activating factor-dependent transacetylase activity and arachidonate release by ATP in endothelial cells. 1998 Prostaglandins Other Lipid Mediat. pmid:9990678
Tiemann U et al. Influence of ovarian steroid hormones or platelet-activating factor on mRNA of platelet-activating factor receptor in endometrial explant perfusion cultures from ovariectomized bovine. 2005 Prostaglandins Other Lipid Mediat. pmid:15967160
Kudolo GB and DeFronzo RA Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus. 1999 Prostaglandins Other Lipid Mediat. pmid:10410380
Tsutsumi T et al. Movement of monoglyceride derived from hydrolysis of fluorescence-labeled lyso platelet-activating factor by lysophospholipase C through plasma membranes of porcine kidney epithelial cell line LLC-PK1. 2007 Prostaglandins Other Lipid Mediat. pmid:17259070
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Itadani K et al. Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands. 1998 Prostaglandins Other Lipid Mediat. pmid:9653774
Fallani A et al. Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. 2006 Prostaglandins Other Lipid Mediat. pmid:17085325
Argyrou C et al. Postprandial effects of wine consumption on Platelet Activating Factor metabolic enzymes. 2017 Prostaglandins Other Lipid Mediat. pmid:28323197